RxDoctor Payments Data

Maya Reid

Optometrist · Litchfield, ILNPI 1225390883

Payments from drug & device makers

$3,337in general payments, 2019–2025

Across 35 payments — averaging $95.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson Vision Care, Inc.$2K
  • AbbVie$409
  • Bausch & Lomb Americas Inc.$296
  • Harrow Eye, LLC$168
  • LKC Technologies, Inc.$157
  • Maculogix, Inc.$117
  • plus $396 from 8 others

What the payments were for

  • Consulting fees$1,72552%
  • Food & beverage$1,61248%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,337 in reported general payments places this provider in the 90th percentile of 2,257 optometrist providers in Illinois.

See all optometrist providers in Illinois

Medicare billing

Part B allowed, 2024
$165,173
Medicare patients
709
Services billed
8,166

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RestasisCyclosporine43$35,627
XdemvyLotilaner19$34,811
LumiganBimatoprost65$31,735
VevyeCyclosporine11$9,228
CombiganBrimonidine Tartrate/Timolol21$8,009
Restasis MultidoseCyclosporine11$7,122
IyuzehLatanoprost/Pf14$4,192
Latanoprost195$1,737
Prednisolone Acetate46$985
Travoprost11$926
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat45$921
Brimonidine Tartrate66$612
Timolol Maleate56$484
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha23$133
Dorzolamide Hcl12$83

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieRestasis, Lumigan, Combigan, Restasis Multidose$409$82,493140 claims
Tarsus Pharmaceuticals, Inc.Xdemvy$110$34,81119 claims
Harrow Eye, LLCVevye$168$9,22811 claims
Thea Pharma Inc.Iyuzeh$19$4,19214 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,257 optometrist providers in Illinois.

Other optometrist in Litchfield

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →